Annual report
160A.TEDINET S100YIQV
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 90
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.7bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥17.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥17.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.8bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.5bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.6bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥866m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥244m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥298m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.6bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.3bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥957m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥564m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥230m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥485m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥24.4bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥21.4bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥16.0bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.7bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥19.2bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥17.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.2bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.1bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.9bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.1bn | at 2026-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2024-03-31v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2023-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.9bn | at 2022-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥4.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥776m | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥745m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥339m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.4bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥708m | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥928m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥599m | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥4.5bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥884m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥369m | 2021-04-01 → 2022-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥330.9 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥269.74 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.81 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥171.95 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥327.52 | 2025-04-01 → 2026-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥266.57 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥70 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥38 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥800 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥800 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,440.46 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,164.14 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥785.49 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥615.49 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥555.68 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 21.2% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.9% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 12.7% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 25.4% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 29.2% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 26.6% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.0% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 35.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,587,400 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,576,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,030,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,600 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 60,600 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 985 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 879 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 811 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 721 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 680 | at 2022-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 55
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-04-01 → 2026-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2025-04-01 → 2026-03-31 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥131m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥131m |
| Reconciling Itemsreconciling | segment assets | at 2026-03-31 | ¥2.5bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥1.9bn |
| Nursing Care And Senior Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥229m |
| Nursing Care And Senior Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥83m |
| Nursing Care And Senior Businessreportable segment | employees | at 2026-03-31 | 898 pure |
| Nursing Care And Senior Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Nursing Care And Senior Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Nursing Care And Senior Businessreportable segment | segment assets | at 2026-03-31 | ¥9.3bn |
| Nursing Care And Senior Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.4bn |
| Real Estate Businessreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥5.0bn |
| Real Estate Businessreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥113m |
| Real Estate Businessreportable segment | employees | at 2026-03-31 | 12 pure |
| Real Estate Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥8.3bn |
| Real Estate Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥8.2bn |
| Real Estate Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥131m |
| Real Estate Businessreportable segment | segment assets | at 2026-03-31 | ¥12.5bn |
| Real Estate Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥5.2bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥196m |
| —segment total | employees | at 2026-03-31 | 910 pure |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥23.8bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥23.7bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥131m |
| —segment total | segment assets | at 2026-03-31 | ¥21.8bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥3.4bn |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥17m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2025-03-31 | −¥184m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2025-03-31 | −¥184m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.8bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥1.8bn |
| Nursing Care And Senior Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥74m |
| Nursing Care And Senior Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥61m |
| Nursing Care And Senior Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| Nursing Care And Senior Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥13.7bn |
| Nursing Care And Senior Businessreportable segment | segment assets | at 2025-03-31 | ¥8.1bn |
| Nursing Care And Senior Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Real Estate Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥5.0bn |
| Real Estate Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥133m |
| Real Estate Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| Real Estate Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.2bn |
| Real Estate Businessreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥184m |
| Real Estate Businessreportable segment | segment assets | at 2025-03-31 | ¥10.5bn |
| Real Estate Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.6bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥5.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥195m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥18.1bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥17.9bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥184m |
| —segment total | segment assets | at 2025-03-31 | ¥18.6bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 985
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 49600 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0138 | |
| Number of shares held | CurrentYearInstant | 2466132 | |
| Shareholding ratio | CurrentYearInstant | 0.6870 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 3579800 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 35798 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesLessThanOneUnitMember | 7600 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 3587400 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 35798 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | － | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | － | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | － | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 251118000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 70.00 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.33 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000UemuraKenjiMember | 1412600 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ItoHirotoshiMember | 152600 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MatsuoAtsundoMember | 57600 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000YamamotoKoujiMember | 152600 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000OgataKatsuyoshiMember | 10000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ItoHanayoMember | 10000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000OkudaKeiichiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000MoriwakiHitokoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E39448-000ShioikeTomokoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 1795400 | |
| Audit fees reporting company | Prior1YearDuration | 20500000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 21000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 78088000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 75360000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 2728000 | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 6000000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 6000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Non monetary remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |